Europe Mulls Rival Approaches to Tackling Disease

In this ISSUE

International Patient Recruitment: The Grass is Not Always Greener Abroad

Cancer Immunotherapy Biomarkers: Four Trends to Watch

European Healthcare Confronted with a Brexit Mouse

Disease Research

Closer Pharma-Diagnostic Collaboration is Key to Alzheimer's Drug R&D

Pharma and diagnostics companies need to strengthen alignment in Alzheimer's disease research–to help turn science and data into actionable medical innovations.
... /Read more/

Expanding patient access to clinical trials is an ongoing challenge. One solution is designed to allow patients with serious and complex diseases to participate in research in the comfort of their own physicians' offices. Read the Applied Clinical Trials interview to learn more from Syneos Health and Elligo Health Research experts talking about their new partnership enabling enhanced access by creating a system of accelerated research (SOAR).

Click Here

The FDA

FDA Initiatives Advance Orphan Therapies

As FDA continues to advance the role of patients in designing clinical trials with meaningful and accurate endpoints, it is seeking more input from stakeholders on how best to identify clinical outcomes most important to patients and caregivers.
... /Read more/

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand

Learn More

Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
On Demand

Learn More

Calendar

/ Clinical Trial Legal and Contracting Forum 12/4-12/5 /

/ Clinical Trial Financial Management Summit 12/5-12/6 /

/ 14^th Biosimilars Summit 1/22/19-1/23/19 /

/ Clinical Data Disclosure and Transparency 1/29/19-1/30/19 /

/ Patient Registries and Real-World Evidence Summit 1/30/19-1/31/19 /

/ DIA Europe 2019 2/5/19-2/7/19 /

IDENTIFYING NASH PATIENTS: Solutions and Strategies
On Demand

Learn More

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Blockchain

Blockchain in Research, from Business to Personal

Blockchain is moving toward definitive uses in clinical trials to enhance clinical supply capabilities, with the potential of enabling data ownership for patients.
... /Read more/

The Potential for Disease-Modifying Therapies in Parkinson's Disease
On Demand

Learn More

Disease

Europe Mulls Rival Approaches to Tackling Disease

Policy discussions include focus on targeted treatments on one side and wider access and prevention-over-treatment on the other.
... /Read more/

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand

Learn More

Patient Connectivity

Janssen Tackles Patient Connectivity

In this interview, Katie Mazuk, Global Head Investigator & Patient Engagement, will discuss her perspectives on improving patient connectivity.
... /Read more/

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

website / blog / advertise / subscribe